Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

The Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) program was initiated by the International Organization for the Study of Inflammatory Bowel Diseases (IOIBD). It examined potential treatment targets for inflammatory bowel disease (IBD) to be used for a "treat-to-target" clinical management strategy using an evidence-based expert consensus process.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Am. J. Gastroenterol.

Title: The American journal of gastroenterology

ISSN (Electronic): 1572-0241

ISSN (Print): 0002-9270

Publication date (Electronic): Sep 2015

Volume: 110

Issue: 9

Affiliations

[1 ] INSERM Unité 954 and Department of Hepato-Gastroenterology, University Hospital of Nancy, University of Lorraine, Houdemont, France.

[2 ] Division of Gastroenterology, University of California San Diego, La Jolla, California, USA.

[3 ] Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

[4 ] McMaster University, Hamilton, Ontario, Canada.

[5 ] Medical University of Vienna, Vienna, Austria.

[6 ] Department of Surgery, Academic Medical Center, Amsterdam, The Netherlands.

[7 ] Translational Gastroenterology Unit, John Radcliffe Hospital, Oxford, UK.

[8 ] Department of Gastroenterology, Academic Medical Centre, Amsterdam, The Netherlands.

[9 ] Inflammatory Bowel Disease Center, Department of Gastroenterology and Liver Diseases, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

[10 ] Division of Pediatric Gastroenterology and Hepatology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

[11 ] University of Western Ontario, London, Ontario, Canada.

[12 ] Inflammatory Bowel Disease Center, Department of Gastroenterology, Humanitas Research Hospital, Rozzano, Milan, Italy.

[13 ] Department of Medicine, University of Otago, Christchurch, New Zealand.

[14 ] Columbia University Division of Digestive and Liver Diseases, New York, New York, USA.

[15 ] First Department of Medicine, Semmelweis University, Budapest, Hungary.

[16 ] Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.

[17 ] AP-HP, Department of Digestive Diseases, Hôpital Lariboisière Medicosurgical and University Denis Diderot, Paris, France.

[18 ] North Zealand Hospital, Capital Region, University of Copenhagen, Copenhagen, Denmark.

[19 ] Inflammatory Bowel Disease Group, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada.

[20 ] Department of Gastroenterology, Hospital Clinic of Barcelona, IDIBAPS, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Barcelona, Spain.

[21 ] Inflammatory Bowel Disease Clinic University of Calgary, Calgary, Alberta, Canada.

[22 ] Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada.

[23 ] Division of Gastroenterology, CHU Sherbrooke, Sherbrooke, Quebec, Canada.

[24 ] Section of Gastroenterology, Hepatology and Nutrition, University of Chicago Medicine, Chicago, Illinois, USA.

[25 ] Dartmouth-Hitchcock Inflammatory Bowel Disease Center, Hanover, New Hampshire, USA.

[26 ] Zane Cohen Centre for Digestive Diseases, Division of Gastroenterology, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada.

[27 ] Department of Radiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

[28 ] Department of General Internal Medicine, Christian-Albrechts-University, University Hospital Schleswig Holstein, Kiel, Germany.

[29 ] Division of Gastroenterology, University of Leuven, Leuven, Belgium.

[30 ] University of Toronto, Toronto, Ontario, Canada.

[31 ] Service des Maladies de l'Appareil Digestif et INSERM U991, CHU Pontchaillou et Université de Rennes 1, Rennes, France.

[32 ] Department of Hepato-Gastroenterology, Claude Huriez Hospital, Université Lille Nord de France, Lille, France.

[33 ] Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.

[34 ] Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

Article

Publisher Item ID: ajg2015233

DOI: 10.1038/ajg.2015.233

PubMed ID: 26303131

SO-VID: 8544cbed-a4e1-453c-9bf8-750f777702d0

History

Data availability:

Comments

Comment on this article

scite_

Cited by 578

See all cited by